HU LIAO, M.D., Ph.D.Chief Physician, Deputy DirectorDept. of Thoracic Surgery, West China Hospital, Sichuan UniversityPI, National Clinical Research Center for Geriatric MedicineEmail: liaotiger_198653@163.comEducation & TrainingVisiting Scholar, Duke University School of Medicine, USA (2018–2019)M.D.-Ph.D., Clinical Medicine (Eight-Year Program), Sichuan University (2005–2013)Clinical ExpertiseMinimally invasive thoracic surgery: VATS lobectomy, segmentectomy, wedge resectionHybrid surgery: VATS combined with image-guided ablation for multi-primary lung cancerThermal ablation: radiofrequency (RFA), microwave, and cryoablation for lung tumors>700 major surgeries/year (99% minimally invasive); 220+ hybrid surgeries performedResearch InterestsMulti-primary lung cancer; hybrid surgery; geriatric lung cancer decision models; perioperative rehabilitation; neuroregulation-enhanced immunotherapy.Selected Publications1. Liao H, et al. Sciatic nerve stimulation enhances NK cell cytotoxicity through dopamine signaling. Drug Resist Updat. 2025;79:101257.2. Liao H, et al. Neoadjuvant immunotherapy plus chemotherapy in NSCLC: A meta-analysis. MedComm. 2025;6(6):e70045.3. Liao H, et al. Digital therapeutics-based cardio-oncology rehabilitation for lung cancer: RCT. JMIR Mhealth Uhealth. 2025;13:e70236.4. Liao H, et al. Targeting Rab26 to overcome cisplatin resistance with DNA nanomaterials. Biomacromolecules. 2023;24(5):2063–2074.5. Liao H, et al. AI-based prediction of outcomes in immunotherapy and targeted therapy. Semin Cancer Biol. 2022;86:146–159.Total: 75 peer-reviewed papers; h-index: 19; citations: 1,148Grants & InnovationsPI of 10+ grants totaling >¥9,000,000 (~$1.25M)First inventor: 6 invention patents, 5 utility model patentsDeveloped Huaxi Smart Endoscopic Training System; deployed in 260+ hospitalsHonors & Professional SocietiesFirst Prize, Sichuan Provincial Science and Technology Progress AwardStanding Committee, Wu Jieping Medical FoundationMember, CSCO Smart Medicine Committee; Member, China Anti-Cancer Association (Tumor Ablation)Vice Chairman, Sichuan AI & Oncology Committee